Linden Thomas Advisory Services’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $683K | Buy |
27,466
+10,403
| +61% | +$259K | 0.08% | 357 |
|
|
2025
Q1 | $529K | Buy |
17,063
+1,816
| +12% | +$56.3K | 0.07% | 368 |
|
|
2024
Q4 | $481K | Buy |
15,247
+2,883
| +23% | +$90.9K | 0.06% | 387 |
|
|
2024
Q3 | $716K | Buy |
12,364
+1,872
| +18% | +$108K | 0.1% | 324 |
|
|
2024
Q2 | $426K | Buy |
10,492
+952
| +10% | +$38.6K | 0.07% | 374 |
|
|
2024
Q1 | $401K | Buy |
9,540
+330
| +4% | +$13.9K | 0.06% | 378 |
|
|
2023
Q4 | $353K | Buy |
9,210
+1,942
| +27% | +$74.4K | 0.07% | 361 |
|
|
2023
Q3 | $224K | Buy |
7,268
+933
| +15% | +$28.8K | 0.05% | 370 |
|
|
2023
Q2 | $200K | Buy |
+6,335
| New | +$200K | 0.04% | 357 |
|